HIGH BASELINE PATIENT’S COMPARED WITH EVALUATOR’S GLOBAL ASSESSMENT IS ASSOCIATED WITH LOWER RETENTION AND REMISSION RATES OF FIRST TNF INHIBITOR IN AXSPA PATIENTS – DATA FROM THE EUROSPA COLLABORATION

Brigitte Michelsen, Lykke Midtbøll Ørnbjerg, A. G. Loft, J. Sexton, A. Ciurea, H. Mann, K. Eklund, A. Yazici, M. J. Santos, J, Askling, Z. Rotar, B. Gudbjornsson, M. Pombo-Suarez, C. Codreanu, I. van der Horst-Bruinsma, E. Kristianslund, M. Nissen, K. Pavelka, N. Trokovic, N. InancE. Vieira-Sousa, D. Di Giuseppe, M. Tomsic, A. J. Geirsson, R. Ionescu, M. van de Sande, F. Iannone, C. Sánchez-Piedra, G. T. Jones, Lise Hejl Hyldstrup, N. S. Krogh, Merete Lund Hetland, Mikkel Østergaard

OriginalsprogEngelsk
ArtikelnummerFRI0403
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind78
Udgave nummerSuppl. 2
Sider (fra-til)887-888
Antal sider2
ISSN0003-4967
StatusUdgivet - 2019

Citationsformater